Dysphagia Management Market Segmented By Product Type: Drugs (Proton Pump Inhibitors), Feeding Tubes (Naso-Gastric Tubes, PEG Tubes), Nutritional Solutions (Thickeners, Beverages, Purees); By Indication: Oropharangeal Dysphagia, Esophageal Dysphagia; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Specialty Clinics

Oropharyngeal dysphagia (OD) has been the highly prevalent form of dysphagia, according to indications of research studies and surveys. However, greater prominence of OD has been observed among the elderly patient population. While OD remains among the most predominant precursors to the growth of dysphagia management market, a new Persistence Market Research (PMR) study expects an overall healthy growth outlook for the global dysphagia management market.

Towards the end of the next decade, the demand for dysphagia management solutions is likely to account for the revenues of more than US$ 6 Bn, and the prevalence rate of OD is anticipated to be rising by 30-40%, in independently living elderly people.

Increasing prevalence of various cancers, especially oral cancer, increases the problem of dysphagia in many people. Moreover, some cancer treatments may also cause swallowing difficulties, as a side effect, leading to an increased need of proper dysphagia management to avoid further resulting complications.

Neurological Causes of Dysphagia Such as Parkinson’s and Stroke to Fuel the Dysphagia Management Market Growth

The onset of Parkinson’s disease and stroke also increases the rate of dysphagia affected patients. Studies suggest that ~50% of Parkinson’s patients show symptoms consistent with oropharyngeal dysphagia. This, in turn, is propelling the demand for dysphagia management products. Dysphagia management has become imperative in geriatric as well as pediatric population, in the backdrop of serious consequences of choking. Several options available for dysphagia management involve the usage of proton pump inhibitors, feeding tubes, and nutritional solutions such as thickeners and beverages. Suitable dysphagia management option is chosen on the basis of the severity of the condition.

Dysphagia is one of the major side effects of smoking cigarette for a prolonged duration. While smoking tobacco tends to kill around 6 million people per year, this fuels the growth of the dysphagia management market gradually due to rising incidence of oropharyngeal cancers. In developed nations, lack of availability of work and excess free time instigates smoking in contrast to developing nations.

Increasing Cases of Stroke to Heighten the Demand for Dysphagia Management

Insufficient blood supply (oxygen and nutrients) to the brain leads to cerebrovascular accident causing strokes. According to a recent study carried out in the U.K. by stroke association, 40% of the stroke survivors suffer from dysphagia. This provide momentum to the dysphagia management market. According to World Heart Association, the incidence rate of stroke at the global front is ~ 15 Mn, out of which ~ 6 Mn people die and 6 Mn are left disabled, leading to loss of vision and speech disability. Thus, the increasing prevalence of stroke leading to dysphagia and other complications related to pharynx and larynx are boosting the growth of the dysphagia management market.

Dysphagia Management Penetrating Rapidly in Asia Pacific

In terms of value, Asia Pacific is estimated to be the prominent market for dysphagia management, in 2019, and is expected to expand at a steady CAGR over the forecast period. While this can be attributed to a high number of pediatric population within the developing countries within the region, so, increasing number hospital and retail pharmacies also contribute to the availability of dysphagia management avenues in these regions. North America is expected to closely follow the Asia pacific region and is anticipated to grow at a CAGR of ~ 5% in the dysphagia management market.  

Business Expansion Remains the Focal Point in Dysphagia Management Market

Some of the key players operating in the dysphagia management market are -

• Eisai Co. Ltd.
• Becton
• Dickinson and Company (BD)
• AstraZeneca Plc.
• Cipla Limited
• Nestlé (Nestlé Health Science)
• Kent Corporation
• Danone
• Cook Group (Cook Medical Inc.)

One of the key strategies adopted by prominent market participants in the dysphagia management landscape includes channelization of their focus on acquiring smaller players in the dysphagia market. Additionally, they are expected to maintain the focus on business expansion in the dysphagia management space, across the nations other than their primary regional markets.

For instance, in December, 2017, Becton, Dickinson and Company (BD) acquired Bard, with an objective to achieve manifold expansion of the dysphagia management business. More recently in April, 2018, Nestle announced heavy investments as worth as ~ US$ 150 Mn in its two manufacturing units based in China, to expand in the nutritional products space, thereby pushing the growth of their dysphagia management business.

Analyst’s Viewpoint

A comprehensive perspective of the dysphagia management market has led our research analysts to infer that the market is growing at a remarkable rate, with Asia Pacific and North America leading the global market and its product offerings.

The rising number of neurological diseases and disorders are anticipated to provide huge growth opportunities for the key players in the dysphagia management market. Also, the problem of dysphagia linked to post-cancer treatment remains as contributing factor in the growth of the global dysphagia management market.